Author: BusinessWire

Alliance will enable a faster and more rigorous approach to biomarker discovery and companion diagnostic co-development IRVINE, Calif.–(BUSINESS WIRE)–Cellgen Diagnostics,…

Pre-clinical data demonstrates first-in-class MERTK selective inhibitor with novel mechanism of action Rgenix has initiated IND-enabling studies of RGX-019 NEW…

WATERTOWN, Mass.–(BUSINESS WIRE)–Tarveda Therapeutics, Inc., a clinical stage biopharmaceutical company discovering and developing a new class of potent and selective…

TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/healthscience?src=hash" target="_blank"gt;#healthsciencelt;/agt;–The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce its 2019 Capital Access Advisory Program (CAAP®)…

BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that Jayson Dallas, M.D.,…

DUBLIN–(BUSINESS WIRE)–The “Artificial Intelligence in Life Sciences Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added…

PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (Nasdaq: ADXS) (the “Company”), a late-stage biotechnology company focused on the discovery, development and commercialization of…

CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24KALV&src=ctag" target="_blank"gt;$KALVlt;/agt;–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the…

ST. HELIER, Jersey–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AACR19?src=hash" target="_blank"gt;#AACR19lt;/agt;–The recipients of the AACR-Novocure Tumor Treating Fields research grants were announced on April 2…

OXFORD, England & CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces that the U.S. Food…